Asset Details
Do you wish to reserve the book?
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Do you wish to request the book?
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
2007
Overview
The risks and benefits of standard antidepressants for patients with bipolar disorder are not well understood. In this randomized, placebo-controlled trial of patients with bipolar disorder, all of whom received a mood stabilizer, adjunctive treatment with an antidepressant did not reduce the symptoms of bipolar depression or increase the risk of mania.
In patients with bipolar disorder, all of whom received a mood stabilizer, adjunctive treatment with an antidepressant did not reduce the symptoms of bipolar depression or increase the risk of mania.
Bipolar disorder, the sixth-leading cause of disability worldwide,
1
is a chronic and recurrent psychiatric illness with a lifetime prevalence of just under 4%
2
and annual costs that exceed those of diabetes or recurrent (unipolar) major depressive disorder.
3
Although abnormal mood elevation is the cardinal diagnostic feature that distinguishes bipolar disorder from recurrent major depressive disorder, depression that alternates with manic episodes (bipolar depression) is the leading cause of impairment and death among patients with bipolar disorders.
4
–
6
Two main limitations related to standard antidepressant medications hamper their use in the treatment of bipolar depression. First, though these agents have proved . . .
Publisher
Massachusetts Medical Society
Subject
/ Antidepressive Agents, Second-Generation - adverse effects
/ Antidepressive Agents, Second-Generation - therapeutic use
/ Antimanic Agents - adverse effects
/ Antimanic Agents - therapeutic use
/ Biological and medical sciences
/ Bipolar Disorder - drug therapy
/ Female
/ Humans
/ Male
/ Paroxetine - therapeutic use
/ Pharmacology. Drug treatments
/ Psychology. Psychoanalysis. Psychiatry
/ Studies
